These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 33589561)
1. Real-world Risk of Relapse of Giant Cell Arteritis Treated With Tocilizumab: A Retrospective Analysis of 43 Patients. Clément J; Duffau P; Constans J; Schaeverbeke T; Viallard JF; Barcat D; Vernhes JP; Sailler L; Bonnet F J Rheumatol; 2021 Sep; 48(9):1435-1441. PubMed ID: 33589561 [TBL] [Abstract][Full Text] [Related]
2. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice. Calderón-Goercke M; Loricera J; Aldasoro V; Castañeda S; Villa I; Humbría A; Moriano C; Romero-Yuste S; Narváez J; Gómez-Arango C; Pérez-Pampín E; Melero R; Becerra-Fernández E; Revenga M; Álvarez-Rivas N; Galisteo C; Sivera F; Olivé-Marqués A; Álvarez Del Buergo M; Marena-Rojas L; Fernández-López C; Navarro F; Raya E; Galindez-Agirregoikoa E; Arca B; Solans-Laqué R; Conesa A; Hidalgo C; Vázquez C; Román-Ivorra JA; Lluch P; Manrique-Arija S; Vela P; De Miguel E; Torres-Martín C; Nieto JC; Ordas-Calvo C; Salgado-Pérez E; Luna-Gomez C; Toyos-Sáenz de Miera FJ; Fernández-Llanio N; García A; Larena C; Palmou-Fontana N; Calvo-Río V; Prieto-Peña D; González-Vela C; Corrales A; Varela-García M; Aurrecoechea E; Dos Santos R; García-Manzanares Á; Ortego N; Fernández S; Ortiz-Sanjuán F; Corteguera M; Hernández JL; González-Gay MÁ; Blanco R Semin Arthritis Rheum; 2019 Aug; 49(1):126-135. PubMed ID: 30655091 [TBL] [Abstract][Full Text] [Related]
3. Relapse Risk and Safety of Long-Term Tocilizumab Use Among Patients With Giant Cell Arteritis: A Single-Enterprise Cohort Study. Samec MJ; Rakholiya J; Langenfeld H; Crowson CS; Abril A; Wang B; Mertz L; Rodriguez-Pla A; Bansal P; Burke M; Jaquith J; Weyand C; Warrington KJ; Koster MJ J Rheumatol; 2023 Oct; 50(10):1310-1317. PubMed ID: 37321636 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations. Unizony S; McCulley TJ; Spiera R; Pei J; Sidiropoulos PN; Best JH; Birchwood C; Pavlov A; Stone JH Arthritis Res Ther; 2021 Jan; 23(1):8. PubMed ID: 33407817 [TBL] [Abstract][Full Text] [Related]
5. Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis. Matza MA; Dagincourt N; Mohan SV; Pavlov A; Han J; Stone JH; Unizony SH RMD Open; 2023 Apr; 9(2):. PubMed ID: 37024237 [TBL] [Abstract][Full Text] [Related]
6. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. Samson M; Devilliers H; Ly KH; Maurier F; Bienvenu B; Terrier B; Charles P; Guillevin L; Besancenot JF; Liozon E; Fauchais AL; Loffroy R; Binquet C; Audia S; Seror R; Mariette X; Bonnotte B Eur J Intern Med; 2018 Nov; 57():96-104. PubMed ID: 30054122 [TBL] [Abstract][Full Text] [Related]
7. The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study. Kreis L; Dejaco C; Schmidt WA; Németh R; Venhoff N; Schäfer VS Trials; 2024 Jan; 25(1):56. PubMed ID: 38225579 [TBL] [Abstract][Full Text] [Related]
8. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica. Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883 [TBL] [Abstract][Full Text] [Related]
9. Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study. Schmitt C; Brockwell L; Giraudon M; Zucchetto M; Christ L; Bannert B; Daikeler T; Villiger PM Arthritis Res Ther; 2022 Jun; 24(1):133. PubMed ID: 35659282 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis. de Boysson H; Le Besnerais M; Blaison F; Daumas A; Jarrot PA; Perrin F; Tieulié N; Maria A; Duffau P; Gombert B; Samson M; Espitia O; Lambert M; Mékinian A; Aouba A; Arthritis Res Ther; 2021 May; 23(1):143. PubMed ID: 34011407 [TBL] [Abstract][Full Text] [Related]
14. Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary center. Nielsen MK; Nielsen AW; Donskov AO; Hansen IT; Nielsen BD; Mørk C; Hauge EM; Keller KK Semin Arthritis Rheum; 2024 Jul; 68():152508. PubMed ID: 38981187 [TBL] [Abstract][Full Text] [Related]
16. An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy. Miyabe C; Miyabe Y; Strle K; Kim ND; Stone JH; Luster AD; Unizony S Ann Rheum Dis; 2017 May; 76(5):898-905. PubMed ID: 27927642 [TBL] [Abstract][Full Text] [Related]
17. A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan. Harigai M; Miyamae T; Hashimoto H; Umetsu K; Yamashita K; Nakaoka Y Mod Rheumatol; 2024 Jul; 34(4):775-783. PubMed ID: 37522620 [TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial. Strand V; Dimonaco S; Tuckwell K; Klearman M; Collinson N; Stone JH Arthritis Res Ther; 2019 Feb; 21(1):64. PubMed ID: 30786937 [TBL] [Abstract][Full Text] [Related]
19. Tocilizumab for giant cell arteritis. Antonio AA; Santos RN; Abariga SA Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013484. PubMed ID: 34420204 [TBL] [Abstract][Full Text] [Related]
20. New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension. Stone JH; Spotswood H; Unizony SH; Aringer M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Spiera R; Bao M Rheumatology (Oxford); 2022 Jul; 61(7):2915-2922. PubMed ID: 34718434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]